iO is developing a new approach to clinical trials that leverages technology to improve access, efficiency, and the overall experience.

iO is developing a new approach to clinical trials that leverages technology to improve access, efficiency, and the overall experience.

We are looking at ways to digitize aspects of clinical trials while increasing interoperability and cooperation between study sites and research teams.

We have entered a strategic alliance with Pfizer to develop, test, and implement solutions to advance clinical trials by incorporating new technologies. This work includes using digital tools, such as Fast Healthcare Interoperability Resources or FHIR, to better identify patients and complete enrollment, optimize the patient experience, and improve data collection and return. In doing so, we will limit study cycle time; increase patient access, recruitment and retention; and enhance the overall patient experience.

This innovative partnership was featured by MedCity News, HealthLeaders Magazine, and HIT Infrastructure, among others.